Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Famvir approved by FDA for new indication

Sep. 22, 1997

Vaxar: first launch for new fluoroquinolone

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

New cephalosporins from Il-Dong

Sep. 19, 1997

Searle evaluates novel target for antifungal agents

Sep. 17, 1997

Antiviral benzimidazole compounds prepared at Glaxo Wellcome

Sep. 17, 1997

Takeda claims new carbapenems

Sep. 17, 1997

Eisai discovers potent, optically active triazole antifungal

Sep. 16, 1997

New compounds for influenza targeting cap-dependent endonuclease

Sep. 16, 1997

Glaxo Wellcome develops new influenza sialidase inhibitors

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.